Get the Stockscreener App
5.2699
3.53%
0.1699
Teladoc Health Inc stock is traded at $5.2699, with a volume of 1.03M.
It is up +3.53% in the last 24 hours and up +7.54% over the past month.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms.
See More
Previous Close:
$5.10
Open:
$5.18
24h Volume:
1.03M
Relative Volume:
0.18
Market Cap:
$935.28M
Revenue:
$2.54B
Net Income/Loss:
$-207.36M
P/E Ratio:
-4.4285
EPS:
-1.19
Net Cash Flow:
$151.25M
1W Performance:
+13.55%
1M Performance:
+7.54%
6M Performance:
-30.80%
1Y Performance:
-42.61%
1-Day Range:
$5.1226
$5.325
1-Week Range:
$4.76
$5.4885
52-Week Range:
$4.40
$9.905
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
5.27 | 905.11M | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
186.25 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.10 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.73 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.54 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.59 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Teladoc Health (TDOC): Oppenheimer Adjusts Price Target Amidst C - GuruFocus
Oppenheimer Adjusts Price Target on Teladoc Health to $7 From $12, Maintains Outperform Rating - marketscreener.com
Vanguard Group Inc. Raises Stock Holdings in Teladoc Health, Inc. $TDOC - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Teladoc Health, Inc. expands virtual care to meet broad employee needs for VSP Vision - Traders Union
[144] Teladoc Health, Inc. SEC Filing - Stock Titan
26,647-share Form 144 notice for TDOC (NYSE: TDOC) by Fidelity - Stock Titan
27,083-Share Vesting Sale Filed by TDOC (NYSE: TDOC) - Stock Titan
Carlos Nueno Plana to sell 20,165 TDOC shares via Fidelity (TDOC) - Stock Titan
Teladoc Health Q4 Earnings Call Highlights - Yahoo Finance
UBS Adjusts Price Target on Teladoc Health to $6 From $9, Maintains Neutral Rating - marketscreener.com
TDOC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Insider sale notice: TDOC (NYSE: TDOC) 50,145 restricted shares - Stock Titan
Teladoc Health Q4 2025 Earnings: Revenue Beat, Weak 2026 GuidanceNews and Statistics - IndexBox
Canaccord Genuity Group Has Lowered Expectations for Teladoc Health (NYSE:TDOC) Stock Price - MarketBeat
Canaccord Genuity Lowers Price Target on TDOC to $10, Maintains Buy Rating | TDOC Stock News - GuruFocus
Teladoc projects lower integrated care membership amid ACA subsidy lapse - Healthcare Dive
Teladoc Health (TDOC) Surges 14% After Beating Q4 2025 Estimates - GuruFocus
Demystifying Teladoc Health: Insights From 8 Analyst Reviews - Benzinga
TDOC: BMO Capital Lowers Price Target, Maintains Market Perform Rating | TDOC Stock News - GuruFocus
Teladoc Health (NYSE:TDOC) Given New $6.00 Price Target at TD Cowen - MarketBeat
BMO Capital Markets Issues Pessimistic Forecast for Teladoc Health (NYSE:TDOC) Stock Price - MarketBeat
These Analysts Slash Their Forecasts On Teladoc Health After Q4 Results - Benzinga
Why Teladoc (TDOC) Stock Is Up Today - Yahoo Finance
BofA upgrades Teladoc stock rating on BetterHelp margin outlook By Investing.com - Investing.com Canada
Teladoc Health (NYSE:TDOC) Stock Rating Upgraded by Bank of America - MarketBeat
TDOC's Price Target Lowered by Piper Sandler Amid Overweight Rat - GuruFocus
Teladoc upgraded at BofA on BetterHelp prospects (TDOC:NYSE) - Seeking Alpha
Evercore ISI Group Maintains In-Line Rating for TDOC, Lowers Pri - GuruFocus
Wells Fargo Adjusts Price Target for TDOC, Maintains Equal-Weigh - GuruFocus
Teladoc Health (NYSE:TDOC) Earns Overweight Rating from Piper Sandler - MarketBeat
Teladoc Health Inc. Beats Expectations and Names New Board Members - StocksToTrade
Teladoc Health (TDOC): Analyst Maintains 'Hold' Rating, Lowers P - GuruFocus
Teladoc Health (NYSE:TDOC) Price Target Cut to $6.00 by Analysts at Wells Fargo & Company - MarketBeat
Stifel cuts Teladoc stock price target to $6 on revenue pressures - Investing.com Canada
Teladoc Health, Inc. SEC 10-K Report - TradingView
Teladoc Health (NYSE:TDOC) Shares Up 14.6% on Earnings Beat - MarketBeat
Stifel Nicolaus Cuts Teladoc Health (NYSE:TDOC) Price Target to $6.00 - MarketBeat
Here's What Key Metrics Tell Us About Teladoc (TDOC) Q4 Earnings - Yahoo Finance
Wells Fargo cuts Teladoc stock price target on flat growth outlook - Investing.com Canada
Teladoc Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:TDOC) 2026-02-26 - Seeking Alpha
Teladoc Health Q4 Loss Narrows To US$25 Million Challenging Bearish Profitability Narratives - Sahm
Teladoc Health (TDOC) Surpasses Q4 Expectations with Strong Earnings - GuruFocus
Teladoc Inc earnings beat by $0.04, revenue topped estimates - Investing.com Australia
Teladoc Health Inc (TDOC) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Teladoc Health hosts events in Orlando and Nashville to drive healthcare evolution - Traders Union
Teladoc Health (TDOC) Surpasses Q4 Expectations, Offers Mixed 20 - GuruFocus
TDOC: 2026 guidance projects flat revenue, margin gains, and strong BetterHelp insurance growth - TradingView
Earnings call transcript: Teladoc Inc beats Q4 2025 forecasts, stock rises - Investing.com
Teladoc Health (TDOC) Projects FY26 Revenue Growth - GuruFocus
Teladoc Health (TDOC) Projects Lower Q1 Revenue Than Expected - GuruFocus
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):